PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34600581-8 2021 The effect of shikonin on expression of interleukin-6, interleukin-1beta and tumor necrosis factor-alpha was measured by enzyme linked immunosorbent assay. shikonin 14-22 interleukin 6 Mus musculus 40-53 34600581-13 2021 Meanwhile, shikonin suppressed tumor necrosis factor-alpha-induced invasion, adhesion and migration of fibroblast like synoviocytes and reduced the expression of interleukin-6, interleukin-1beta and tumor necrosis factor-alpha. shikonin 11-19 interleukin 6 Mus musculus 162-175 32279045-6 2020 Furthermore, western blotting and the results of morphological analysis revealed that shikonin treatments markedly reduced D-gal induced neuroinflammation through inhibition of astrocytosis as determined by glial fibrillary acidic protein (GFAP) detection, and downregulating other inflammatory mediators, including tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and IL-6. shikonin 86-94 interleukin 6 Mus musculus 391-395 30818140-9 2019 Furthermore, shikonin markedly attenuated the APAP-induced production of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) and suppressed the expression of genes related to inflammation. shikonin 13-21 interleukin 6 Mus musculus 114-127 30818140-9 2019 Furthermore, shikonin markedly attenuated the APAP-induced production of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1beta (IL-1beta) and suppressed the expression of genes related to inflammation. shikonin 13-21 interleukin 6 Mus musculus 129-133 23651796-5 2013 Furthermore, shikonin significantly reduced the concentrations of TNF-alpha, IL-6 and IL-1beta in bronchoalveolar lavage fluid induced by LPS. shikonin 13-21 interleukin 6 Mus musculus 77-81 33313945-5 2021 Following shikonin treatment, the accumulation of pulmonary neutrophils and expression of TNFalpha, IL-1beta and IL-6 were decreased in mice with LTA-induced ALI. shikonin 10-18 interleukin 6 Mus musculus 113-117 23201088-7 2013 RESULTS: Shikonin administration significantly reduced serum amylase and lipase activities, pancreatic histological scores, TNF-alpha, IL-1beta, IL-6 levels, MPO activity and NF-kappaB activity. shikonin 9-17 interleukin 6 Mus musculus 145-149